Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FA4BM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,316
Award facts
- Contract value 100% obligated
- $41,316.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $41,316.22 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/mL format. This is a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, issued on September 23, 2025. The contract carries no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location. This delivery order falls under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates consistent competitively-awarded delivery orders with firm fixed pricing across a wide spectrum of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies. This specific order for Cosentyx, a biologic immunosuppressant used in treating conditions such as psoriasis and rheumatoid arthritis, supports the Defense Health Agency and other federal healthcare systems' pharmaceutical supply requirements through the comprehensive DLA Troop Support Medical prime vendor contract vehicle.
Quick answers
Who was awarded contract SPE2DB25FA4BM?
SPE2DB25FA4BM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FA4BM worth?
The government has obligated $41,316 on SPE2DB25FA4BM.
Is contract SPE2DB25FA4BM an order under another contract?
Yes. SPE2DB25FA4BM is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB25FA4BM competed?
The extent of competition for SPE2DB25FA4BM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award